Search for: "Lewis et al v. General Motors Corporation et al" Results 1 - 14 of 14
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2018, 2:40 pm
I am happy to report the publication of my article,  "The Corporate Social Responsibilities of Financial Institutions for the Conduct of their Borrowers: The View From International Law and Standards," Lewis & CLark Law Review 21(4):881-920 (2018). [read post]
30 Dec 2014, 6:00 am by Daniel E. Cummins
County of Lackawanna et al., No. 2007-CV-2401 (C.P. [read post]
30 Mar 2020, 4:00 am by Ed. Microjuris.com Puerto Rico
También examinaremos el tratamiento que el proyecto de Código de Conducta Profesional imparte al posible uso de estas aplicaciones, redes y softwares sociales por parte de abogados y abogadas con el propósito de dar publicidad a sus servicios. [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360)   Global - Copyright Expanding the public domain: part zero (Creative Commons)     Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]